Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2764.85	2654.12	92.64
Graham Fair Price	-87.66	62.68	508.13
PEG	12133.67	7.82	-0.06
Price/Book	-6.13	0.35	0.38
Price/Cash Flow	-82.24	81.31	-457.83
Prices/Earnings	-6189.32	-770.02	-12.24
Price/Sales	-6.92	2.38	2.55
Price/FCF	-82.24	81.31	-457.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-21.05	0.41	0.52
Operating Margin	124.13	-0.02	< 0.005
ROA	98.48	< 0.005	< 0.005
ROE	< 0.005	< 0.005	98.51
ROIC	< 0.005	< 0.005	-83.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.19	0.36	-46.47
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.34	-3.28	875.58
EPS QOQ	-1.92	0.99	-48.59
FCF QOQ	-1.97	6.34	221.82
Revenue QOQ	0.02	0.02	-9.26
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	215.53	165.95	-23.00
Days Sales Outstanding (DSO)	50.64	57.45	13.45
Inventory Turnover	0.42	0.54	29.88
Debt/Capitalization	0.15	0.12	-19.56
Quick Ratio	0.80	0.79	-2.27
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1221.68	1233.51	0.97
Cash	129.39	91.33	-29.41
Capex	-1.40	-0.55	60.73
Free Cash Flow	-1.00	5.36	433.68
Revenue	180.24	183.53	1.83
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.65	1.68	1.67
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.29	416.35	2813.86
Naive Interpretation	Member

06 - Financial Health · Weak

Rating